Biotech Values

[biomaven0]

‘What is the probability that any patient who showed cognitive improvement was receiving PBT2?

That seems a pretty backwards way to analyze the results. I assume they phrased it this way because a conventional question came out non-significant? Intuitively I'm guessing it might imply that while many patients did better on the drug, some subset also did significantly worse.

Peter